O'Reilly MA, Sanderson R, Wilson W, Iyengar S, et al. Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46-62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapse Br J Haematol 2022 Jul 27. doi: 10.1111/bjh.18378.
PMID: 35894253